Sarah Croft
Racial minorities less likely to receive CPR
Black and Hispanic individuals experiencing a cardiac arrest either at home or in public are substantially less likely to receive cardiopulmonary resuscitation (CPR) from...
Kirigami meets electrocardiology: an electrocardiogram monitor app is born
Researchers want to leverage the centuries-old art of cutting paper into designs to develop a sensor sheet that can stretch and breathe alongside the...
AF Symposium 2022: Lower pulmonary vein to left atrium volume ratio...
Pulmonary vein-left atrial (PV/LA) volume ratio is a significantly better predictor power for atrial fibrillation (AF) recurrence than LA dimension in patients with normal...
AF Symposium 2022: Latest evidence for lattice tip catheter ablation strategies...
Pulsed-field ablation (PFA) and/or radiofrequency ablation (RFA) using a lattice-tip catheter can both isolate pulmonary veins (PVs) and create linear lesions efficiently and safely,...
DiA Imaging Analysis announces partnership with Healthcare Technology to expand AI...
DiA Imaging Analysis Ltd, announced today a multi-year agreement with Change Healthcare. Change Healthcare's proven cardiology solutions, along with DiA's AI-based algorithms, will benefit...
Telehealth accessible for diverse paediatric electrophysiology patient population
As a result of the COVID-19 pandemic, the increasing uptake of paediatric electrophysiology (EP) telehealth services has demonstrated clear ability to deliver healthcare for...
Same-day discharge for catheter ablation of atrial fibrillation deemed safe and...
A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...
Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment
Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Alternative timing method for direct oral anticoagulants following ischaemic stroke with...
A new timely practice—known as the “1-2-3-4-day” rule—for the administration of direct oral anticoagulants (DOACs) in patients after acute ischaemic stroke or transient ischaemic...
CoreMap finalises US$23 million financing
CoreMap has announced the closure of a US$3 million series A milestone financing, with a US$20 million series B financing, which includes a diverse...
Ceryx Medical launches Cysoni bionic device for respiratory sinus arrhythmia
A collaboration between Ceryx Medical Limited and the scientists at the Auckland Bioengineering Institute (ABI) and the Universities of Bath and Bristol, have developed...
Q-FFICIENCY trial shows promise for temperature-controlled ablation
Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
Study shares success of complete PVI using only pulsed field ablation
A recent study has demonstrated 100% pulmonary vein isolation (PVI) using only pulsed field ablation (PFA), resulting in no PFA-related serious adverse events. This...
Contact force-guided ablation for typical atrial flutter does not reduce recurrent...
Contact-force (CF)-guided ablation to treat typical atrial flutter does not reduce recurrent atrial arrhythmia at 12 months follow-up, in comparison to ablation blinded for...
AtriAN Medical present results of Neural AF trial at AF Symposium...
According to a press release, AtriAN Medicals clinical data from the Neural atrial fibrillation (AF) study was presented by Vivek Reddy (Mount Sinai Hospital,...
MicroPort CRM approved in Japan for Alizea bluetooth pacemaker
MicroPort CRM has recently received the pharmaceuticals and medical devices agency (PMDA) Japanese regulation agency approval for the Alizea range of portable pacemakers. The...
Disparities found in management of hospitalised patients with hypertrophic cardiomyopathy
New research suggests that implantable cardioverter defibrillators (ICDs) are not used as frequently for females and patients of colour, despite the increased use of ICDs...
Trial underway to evaluate “modular” cardiac rhythm management system
Boston Scientific has announced the start of the MODULAR ATP clinical trial to evaluate the safety, performance and effectiveness of the mCRM modular therapy...
AF risk increases during the first year after breast cancer diagnosis in...
Women diagnosed with breast cancer are significantly more likely to develop atrial fibrillation (AF) compared to women without cancer, according to research published in...
Patients with both atrial fibrillation and diabetes less likely to notice...
Adults with type 1 or type 2 diabetes and atrial fibrillation (AF) are less likely to notice irregular heartbeat symptoms, more likely to have...
Caption Health and Ultromics partner to increase availability of heart disease...
Caption Health and Ultromics have announced a strategic partnership to accelerate cardiovascular disease detection and treatment for more patients in more accessible care settings....